Position in LLY
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$13,023,412
+$3,444,008 QoQ
Shares Held
10,858
+4.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.16%
of 13F equity value
Holder Rank
#1,118
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FAS Wealth Partners, Inc. holds $43,360,679 across 8 Drug Manufacturers - General names. LLY ranks #1 (30.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
10,858 | $13,023,412 | |
| 2 | JNJ |
Johnson & Johnson
|
41,193 | $10,461,786 | |
| 3 | ABBV |
AbbVie Inc.
|
32,676 | $8,222,588 | |
| 4 | MRK |
Merck & Co., Inc.
|
43,241 | $5,556,468 | |
| 5 | AMGN |
Amgen Inc
|
12,997 | $4,706,473 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
12,426 | $715,986 | |
| 7 | PFE |
Pfizer Inc
|
17,043 | $410,395 | |
| 8 | AZN |
Astrazeneca PLC
|
1,390 | $263,571 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,023,412 | 10,858 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $9,579,404 | 10,415 | Shares | Sole | 2026-06-10 | |
| 2025-12-31 | $10,816,655 | 10,065 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $7,457,562 | 9,774 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $7,435,936 | 9,539 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $7,404,283 | 8,965 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $6,836,832 | 8,856 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $4,994,929 | 5,638 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $5,005,846 | 5,529 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $4,228,990 | 5,436 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $3,212,472 | 5,511 | Shares | Sole | 2024-01-23 | |
| 2023-09-30 | $2,904,799 | 5,408 | Shares | Sole | 2023-10-23 | |
| 2023-06-30 | $2,470,586 | 5,268 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $2,023,087 | 5,891 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $2,154,065 | 5,888 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $1,906,148 | 5,895 | Shares | Sole | 2022-10-20 | |
| 2022-06-30 | $1,603,317 | 4,945 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $1,440,441 | 5,030 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $1,388,281 | 5,026 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,164,954 | 5,042 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,176,978 | 5,128 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $957,265 | 5,124 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $729,219 | 4,319 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $640,778 | 4,329 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $747,675 | 4,554 | Shares | Sole | 2020-07-21 | |
| 2020-03-31 | $658,642 | 4,748 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||